Brief: Quantum Genomics: new patent approved for United States
Jan 21 (Reuters) - Quantum Genomics SA ALQGC.PA :
* Reported on Wednesday a new patent that has just been
approved for the United States (no. 9187418), along with two
other similar patents for Mexico (no. 222939) and Eurasia (no.
021612)
* These patents, for which the international application was
submitted in October 2011, protect the industrial manufacturing
process of the main active ingredient of the drug candidate
QGC001 until 2031
Source text for Eikon: ID:nACT42823
Further company coverage: ALQGC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study